A subpopulation of endothelial progenitor cells with low aldehyde dehydrogenase activity attenuates acute ischemic brain injury in rats

Biochemical and Biophysical Research Communications

Volumn 418, Issue 1, 2012, Pages 87-92

  Nakamura, Kazuhiro ^a   Tsurushima, Hideo ^a   Marushima, Aiki ^a   Nagano, Masumi ^a   Yamashita, Toshiharu ^a   Suzuki, Kensuke ^b   Ohneda, Osamu ^a   Matsumura, Akira ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Aldehyde dehydrogenase activity; Cell transplantation therapy; CXCR4; Endothelial progenitor cells; SDF 1

Indexed keywords

ALDEHYDE DEHYDROGENASE; CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1;

ACUTE DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; CELL ACTIVITY; CELL MIGRATION; CELL SUBPOPULATION; CELL THERAPY; CELL TRANSPLANTATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIAL PROGENITOR CELL; ENZYME ACTIVITY; HEMISPHERE; HUMAN; HUMAN CELL; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; THERAPY EFFECT; UMBILICAL VEIN ENDOTHELIAL CELL;

ALDEHYDE DEHYDROGENASE; ANIMALS; BRAIN INFARCTION; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; STEM CELL TRANSPLANTATION; STEM CELLS; TREATMENT OUTCOME;

RATTUS;

EID: 84862815915     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.12.139     Document Type: Article

References (36)

1. Bliss T., Guzman R., Daadi M., Steinberg G.K. Cell transplantation therapy for stroke. Stroke 2007, 38:817-826.
2. Oyamada N., Itoh H., Sone M., Yamahara K., Miyashita K., Park K., Taura D., Inuzuka M., Sonoyama T., Tsujimoto H., Fukunaga Y., Tamura N., Nakao K. Transplantation of vascular cells derived from human embryonic stem cells contributes to vascular regeneration after stroke in mice. J. Transl. Med. 2008, 6:54.
3. Chen S.J., Chang C.M., Tsai S.K., Chang Y.L., Chou S.J., Huang S.S., Tai L.K., Chen Y.C., Ku H.H., Li H.Y., Chiou S.H. Functional improvement of focal cerebral ischemia injury by subdural transplantation of induced pluripotent stem cells with fibrin glue. Stem Cells Dev. 2010, 19:1757-1767.
4. Kawai H., Yamashita T., Ohta Y., Deguchi K., Nagotani S., Zhang X., Ikeda Y., Matsuura T., Abe K. Tridermal tumorigenesis of induced pluripotent stem cells transplanted in ischemic brain. J. Cereb. Blood Flow Metab. 2010, 30:1487-1493.
5. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
6. Rafii S., Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 2003, 9:702-712.
7. Urbich C., Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 2004, 95:343-353.
8. Rouhl R.P., van Oostenbrugge R.J., Damoiseaux J., Cohen Tervaert J.W., Lodder J. Endothelial progenitor cell research in stroke: a potential shift in pathophysiological and therapeutical concepts. Stroke 2008, 39:2158-2165.
9. Nagano M., Yamashita T., Hamada H., Ohneda K., Kimura K., Nakagawa T., Shibuya M., Yoshikawa H., Ohneda O. Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood. Blood 2007, 110:151-160.
10. Hess D.A., Meyerrose T.E., Wirthlin L., Craft T.P., Herrbrich P.E., Creer M.H., Nolta J.A. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 2004, 104:1648-1655.
11. Xu G., Nagano M., Kanezaki R., Toki T., Hayashi Y., Taketani T., Taki T., Mitui T., Koike K., Kato K., Imaizumi M., Sekine I., Ikeda Y., Hanada R., Sako M., Kudo K., Kojima S., Ohneda O., Yamamoto M., Ito E. Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome. Blood 2003, 102:2960-2968.
12. Wardlaw J.M., Warlow C.P. Thrombolysis in acute ischemic stroke: does it work?. Stroke 1992, 23:1826-1839.
13. Zanette E.M., Roberti C., Mancini G., Pozzilli C., Bragoni M., Toni D. Spontaneous middle cerebral artery reperfusion in ischemic stroke. A follow-up study with transcranial Doppler. Stroke 1995, 26:430-433.
14. Kato N., Yanaka K., Hyodo K., Homma K., Nagase S., Nose T. Stable nitroxide Tempol ameliorates brain injury by inhibiting lipid peroxidation in a rat model of transient focal cerebral ischemia. Brain Res. 2003, 979:188-193.
15. Oishi K., Itamoto T., Amano H., Fukuda S., Ohdan H., Tashiro H., Shimamoto F., Asahara T. Clinicopathologic features of poorly differentiated hepatocellular carcinoma. J. Surg. Oncol. 2007, 95:311-316.
16. Asahara T. Endothelial progenitor cells for vascular medicine. Yakugaku Zasshi 2007, 127:841-845.
17. Ohta T., Kikuta K., Imamura H., Takagi Y., Nishimura M., Arakawa Y., Hashimoto N., Nozaki K. Administration of ex vivo-expanded bone marrow-derived endothelial progenitor cells attenuates focal cerebral ischemia-reperfusion injury in rats. Neurosurgery 2006, 59:679-686. (discussion 679-686).
18. Ingram D.A., Caplice N.M., Yoder M.C. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 2005, 106:1525-1531.
19. Boyer M., Townsend L.E., Vogel L.M., Falk J., Reitz-Vick D., Trevor K.T., Villalba M., Bendick P.J., Glover J.L. Isolation of endothelial cells and their progenitor cells from human peripheral blood. J. Vasc. Surg. 2000, 31:181-189.
20. Brunt K.R., Hall S.R., Ward C.A., Melo L.G. Endothelial progenitor cell and mesenchymal stem cell isolation, characterization, viral transduction. Methods Mol. Med. 2007, 139:197-210.
21. Murohara T. Autologous adipose tissue as a new source of progenitor cells for therapeutic angiogenesis. J. Cardiol. 2009, 53:155-163.
22. Xue S., Zhang H.T., Zhang P., Luo J., Chen Z.Z., Jang X.D., Xu R.X. Functional endothelial progenitor cells derived from adipose tissue show beneficial effect on cell therapy of traumatic brain injury. Neurosci. Lett. 2010, 473:186-191.
23. Yamahara K., Sone M., Itoh H., Yamashita J.K., Yurugi-Kobayashi T., Homma K., Chao T.H., Miyashita K., Park K., Oyamada N., Sawada N., Taura D., Fukunaga Y., Tamura N., Nakao K. Augmentation of neovascularization [corrected] in hindlimb ischemia by combined transplantation of human embryonic stem cells-derived endothelial and mural cells. PLoS ONE 2008, 3:e1666.
24. Ingram D.A., Mead L.E., Tanaka H., Meade V., Fenoglio A., Mortell K., Pollok K., Ferkowicz M.J., Gilley D., Yoder M.C. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004, 104:2752-2760.
25. Iihoshi S., Honmou O., Houkin K., Hashi K., Kocsis J.D. A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats. Brain Res. 2004, 1007:1-9.
26. Fan Y., Shen F., Frenzel T., Zhu W., Ye J., Liu J., Chen Y., Su H., Young W.L., Yang G.Y. Endothelial progenitor cell transplantation improves long-term stroke outcome in mice. Ann. Neurol. 2010, 67:488-497.
27. Hirouchi M., Ukai Y. Current state on development of neuroprotective agents for cerebral ischemia. Nihon Yakurigaku Zasshi 2002, 120:107-113.
28. He X.Y., Chen Z.Z., Cai Y.Q., Xu G., Shang J.H., Kou S.B., Li M., Zhang H.T., Duan C.Z., Zhang S.Z., Ke Y.Q., Zeng Y.J., Xu R.X., Jiang X.D. Expression of cytokines in rat brain with focal cerebral ischemia after grafting with bone marrow stromal cells and endothelial progenitor cells. Cytotherapy 2011, 13:46-53.
29. Bagri A., Gurney T., He X., Zou Y.R., Littman D.R., Tessier-Lavigne M., Pleasure S.J. The chemokine SDF1 regulates migration of dentate granule cells. Development 2002, 129:4249-4260.
30. Nagasawa T., Hirota S., Tachibana K., Takakura N., Nishikawa S., Kitamura Y., Yoshida N., Kikutani H., Kishimoto T. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996, 382:635-638.
31. Lu W., Gersting J.A., Maheshwari A., Christensen R.D., Calhoun D.A. Developmental expression of chemokine receptor genes in the human fetus. Early Hum. Dev. 2005, 81:489-496.
32. Nagasawa T., Tachibana K., Kishimoto T. A novel CXC chemokine PBSF/SDF-1 and its receptor CXCR4: their functions in development, hematopoiesis and HIV infection. Semin. Immunol. 1998, 10:179-185.
33. Ara T., Itoi M., Kawabata K., Egawa T., Tokoyoda K., Sugiyama T., Fujii N., Amagai T., Nagasawa T. A role of CXC chemokine ligand 12/stromal cell-derived factor-1/pre-B cell growth stimulating factor and its receptor CXCR4 in fetal and adult T cell development in vivo. J. Immunol. 2003, 170:4649-4655.
34. Hill W.D., Hess D.C., Martin-Studdard A., Carothers J.J., Zheng J., Hale D., Maeda M., Fagan S.C., Carroll J.E., Conway S.J. SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J. Neuropathol. Exp. Neurol. 2004, 63:84-96.
35. Chen Y., Stamatoyannopoulos G., Song C.Z. Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res. 2003, 63:4801-4804.
36. Yu K., Zhuang J., Kaminski J.M., Ambati B., Gao Q., Ma P., Liao D., Li F., Liu X., Ge J. CXCR4 down-regulation by small interfering RNA inhibits invasion and tubule formation of human retinal microvascular endothelial cells. Biochem. Biophys. Res. Commun. 2007, 358:990-996.